SCHEMBL17799749

SCHEMBL17799749

O=C(N[C@H]1CC[C@H]1c1ccc(Cl)cc1Cl)c1ccccc1I

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 1/20 0.45
▸ SLC6A12 P48065 1/20 0.42
▸ TAS1R3 Q7RTX0 5/20 0.42
▸ TAS1R1 Q7RTX1 5/20 0.42
▸ TAS1R2 Q8TE23 5/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ F10 P00742 1/20 0.40
▸ HCRTR2 O43614 1/20 0.40
▸ P2RX7 Q99572 1/20 0.39
▸ FAAH O00519 1/20 0.37
▸ MGLL Q99685 1/20 0.37
▸ GRM5 P41594 1/20 0.37
▸ DRD4 P21917 1/20 0.37
▸ SSTR3 P32745 1/20 0.37
▸ DPP4 P27487 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16372239 1.00 SIGMAR1 (0.45) SIGMAR1SLC6A12TAS1R3TAS1R1TAS1R2
SCHEMBL17799743 0.89 SLC6A12 (0.47) SLC6A12TAS1R3TAS1R1TAS1R2NPC1
SCHEMBL17799642 0.86 GRM5 (0.52) SLC6A12TAS1R3TAS1R1TAS1R2KDM4E
SCHEMBL17799710 0.86 NPC1 (0.47) SLC6A12TAS1R3TAS1R1TAS1R2KDM4E
SCHEMBL16372221 0.86 GRM5 (0.52) SLC6A12TAS1R3TAS1R1TAS1R2KDM4E
SCHEMBL17799736 0.86 TAS1R3 (0.49) SLC6A12TAS1R3TAS1R1TAS1R2KDM4E
SCHEMBL16451640 0.83 HCRTR1 (0.45) SLC6A12TAS1R3TAS1R1TAS1R2KDM4E
SCHEMBL15295032 0.83 HCRTR1 (0.45) SLC6A12TAS1R3TAS1R1TAS1R2KDM4E
SCHEMBL15295033 0.83 HCRTR1 (0.45) SLC6A12TAS1R3TAS1R1TAS1R2KDM4E
SCHEMBL17799690 0.83 PPIA (0.41) SLC6A12TAS1R3TAS1R1TAS1R2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50724-E1 4-membered ring carboxamides used as nematicides SYNGENTA CROP PROTECTION AG (CH) 2026-01-06 — — US disclosed
EP-3019476-B1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2018-01-17 — — EP disclosed
US-9867371-B2 4-membered ring carboxamides used as nematicides SYNGENTA PARTICIPATIONS AG (CH) 2018-01-16 — — US disclosed
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES TUBA3C, DDT, CYCS SIGMAR1 916/4885SLC6A12 4180/4885TAS1R3 3195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback